Irritable bowel syndrome laboratory findings
|
Irritable bowel syndrome Microchapters |
|
Differentiating Irritable bowel syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Irritable bowel syndrome laboratory findings On the Web |
|
American Roentgen Ray Society Images of Irritable bowel syndrome laboratory findings |
|
Risk calculators and risk factors for Irritable bowel syndrome laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
An elevated/reduced concentration of serum/blood/urinary/CSF/other [lab test] is diagnostic of [disease name].
OR
Laboratory findings consistent with the diagnosis of [disease name] include [abnormal test 1], [abnormal test 2], and [abnormal test 3].
OR
[Test] is usually normal among patients with [disease name].
OR
Some patients with [disease name] may have elevated/reduced concentration of [test], which is usually suggestive of [progression/complication].
OR
There are no diagnostic laboratory findings associated with [disease name].
Laboratory Findings
- The diagnosis of IBS is based on clinical symptoms and elimination of other organic gastrointestinal diseases. This is due to lack of definitive radiologic or laboratory diagnostic tests in IBS.[1][2][3][4][5]
- If the history and physical exam are suggestive of IBS in the absence of alarm features, the following tests rule out organic causes by 97 percent:
- CBC- normal in IBS
- Occult blood test- normal in IBS
- Complete metabolic panel- normal
- ESR- normal
- Additional tests may be costly and harmful in young patients with typical IBS symtoms, in the absence of alarm features.
- To determine the aggressiveness of the diagnostic evaluation, the American Gastroenterological Association has defined certain factors that must be considered:
- Degree of psychosocial impairment
- Age and sex of the patient
- Family history of colorectal cancer
- Prior diagnostic studies
- Duration of symptoms
- Change in symptoms over time
- In patients that require aggressive diagnostic evaluation, additional diseases need to be ruled out:
- Celiac disease: Serological screening(antiendomysial antibodies)
- IBD:
- Inflammatory markers(ESR, C-reactive protein, plasma viscosity) are likely to be raised
- LFTs- decreased serum albumin
- Complete blood count shows IDA due to blood loss
- Giardiasis: prevalent in developing countries
- stool sample for microscopy
- culture with specific request to look for ova, cyst and parasites
- Lactase deficiency:
- Hydrogen breath test
- Evaluation after a 3-week lactose-free diet.
- Other organic causes are suspected if lab investigations show the following:
- Complete blood count- evidence of anemia
- ESR raised
- Stool Volume >200–300 mL/day
- Stool content: Blood and leukocytes
References
- ↑ Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC (2006). "Functional bowel disorders". Gastroenterology. 130 (5): 1480–91. doi:10.1053/j.gastro.2005.11.061. PMID 16678561.
- ↑ Drossman DA, Camilleri M, Mayer EA, Whitehead WE (2002). "AGA technical review on irritable bowel syndrome". Gastroenterology. 123 (6): 2108–31. doi:10.1053/gast.2002.37095. PMID 12454866.
- ↑ Spiller R, Aziz Q, Creed F, Emmanuel A, Houghton L, Hungin P, Jones R, Kumar D, Rubin G, Trudgill N, Whorwell P (2007). "Guidelines on the irritable bowel syndrome: mechanisms and practical management". Gut. 56 (12): 1770–98. doi:10.1136/gut.2007.119446. PMC 2095723. PMID 17488783.
- ↑ Brandt LJ, Bjorkman D, Fennerty MB, Locke GR, Olden K, Peterson W, Quigley E, Schoenfeld P, Schuster M, Talley N (2002). "Systematic review on the management of irritable bowel syndrome in North America". Am. J. Gastroenterol. 97 (11 Suppl): S7–26. PMID 12425586.
- ↑ Yawn BP, Lydick E, Locke GR, Wollan PC, Bertram SL, Kurland MJ (2001). "Do published guidelines for evaluation of irritable bowel syndrome reflect practice?". BMC gastroenterology. 1: 11. PMID 11701092.